{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:46:10Z","timestamp":1785735970299,"version":"3.56.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T00:00:00Z","timestamp":1785715200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Clear cell renal cell carcinoma (ccRCC) is metabolically primed for ferroptosis, yet the prognostic relevance and mechanistic contribution of ferroptosis-related genes remain incompletely defined. This study aimed to identify ferroptosis-associated biomarkers with prognostic value and to clarify their functional relevance in ccRCC progression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We integrated single-cell RNA sequencing, bulk RNA-seq, spatial transcriptomics, and machine-learning-based feature selection to identify ferroptosis-related prognostic genes in ccRCC. A four-gene risk model and an integrated nomogram were constructed and evaluated in independent cohorts. PANX2 was prioritized for experimental validation using stable knockdown models, RNA sequencing, lipid peroxidation and iron probes, redox assays, Western blot, luciferase reporter assays, xenografts, and an immunocompetent murine renal carcinoma model.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A four-gene prognostic signature (CA9, PVT1, RRM2, and PANX2) was identified and used to construct a risk model with consistent predictive performance in the training and external validation cohorts. Among these genes, PANX2 was predominantly enriched in epithelial tumor compartments and had not been functionally characterized in ccRCC. PANX2 knockdown inhibited ccRCC cell proliferation, reduced antioxidant capacity, increased intracellular Fe\n                      <jats:sup>2+<\/jats:sup>\n                      accumulation and lipid peroxidation, and sensitized cells to erastin-induced ferroptotic death. Mechanistically, PANX2 loss was associated with reduced Akt\/mTOR pathway activity and diminished SLC7A11 expression; rescue with an Akt activator or SLC7A11 overexpression attenuated ferroptosis-associated phenotypes. In an immunocompetent murine renal carcinoma model, PANX2 knockdown was accompanied by increased infiltration of CD45+ leukocytes, CD3+ T cells, and CD8+ T cells, supporting a potential link between PANX2-dependent ferroptosis resistance and the tumor immune contexture.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study identifies PANX2 as a ccRCC-relevant suppressor of ferroptosis and supports the involvement of a PANX2-Akt\/mTOR-SLC7A11-associated signaling axis in redox homeostasis and tumor progression. The ferroptosis-related prognostic model and nomogram may support risk stratification, while PANX2 represents a candidate therapeutic vulnerability that warrants further mechanistic and translational validation.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2026.1883667","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:31:47Z","timestamp":1785735107000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Integrative multi-omics identifies PANX2 as a ferroptosis suppressor and potential therapeutic target in clear cell renal cell carcinoma"],"prefix":"10.3389","volume":"17","author":[{"given":"Xinglin","family":"Li","sequence":"first","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]},{"name":"Medical College, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiqi","family":"Xiong","sequence":"additional","affiliation":[{"name":"Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiyin","family":"Wang","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenying","family":"Qiao","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]},{"name":"Medical College, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqian","family":"Yu","sequence":"additional","affiliation":[{"name":"Medical College, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitao","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Yantai Yuhuangding Hospital of Qingdao University","place":["Yantai, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonghong","family":"Zhang","sequence":"additional","affiliation":[{"name":"Beijing Youan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronghua","family":"Jin","sequence":"additional","affiliation":[{"name":"Beijing Ditan Hospital, Capital Medical University","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dongxu","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Urology, The Affiliated Hospital of Qingdao University","place":["Qingdao, China"]},{"name":"Medical College, Qingdao University","place":["Qingdao, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,8,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g4797","article-title":"Renal cell carcinoma","volume":"349","author":"Jonasch","year":"2014","journal-title":"BMJ"},{"key":"B2","doi-asserted-by":"publisher","first-page":"17009","DOI":"10.1038\/nrdp.2017.9","article-title":"Renal cell carcinoma","volume":"3","author":"Hsieh","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21411","article-title":"Treatment of renal cell carcinoma: Current status and future directions","volume":"67","author":"Barata","year":"2017","journal-title":"CA Cancer J Clin"},{"key":"B4","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.eururo.2018.08.036","article-title":"Epidemiology of renal cell carcinoma","volume":"75","author":"Capitanio","year":"2019","journal-title":"Eur Urol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.56434\/j.arch.esp.urol.20247709.148","article-title":"Computed tomography measures of perinephric adipose tissue and C-reactive protein-to-albumin ratio are associated with common prognostic models for nonmetastatic clear cell renal cell carcinoma patients","volume":"77","author":"Liu","year":"2024","journal-title":"Arch Esp Urol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2012.03.042","article-title":"Ferroptosis: an iron-dependent form of nonapoptotic cell death","volume":"149","author":"Dixon","year":"2012","journal-title":"Cell"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2022.06.003","article-title":"Ferroptosis turns 10: Emerging mechanisms, physiological functions, and therapeutic applications","volume":"185","author":"Stockwell","year":"2022","journal-title":"Cell"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1038\/nature13557","article-title":"Fructose-1,6-bisphosphatase opposes renal carcinoma progression","volume":"513","author":"Li","year":"2014","journal-title":"Nature"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1038\/nmeth.1315","article-title":"mRNA-Seq whole-transcriptome analysis of a single cell","volume":"6","author":"Tang","year":"2009","journal-title":"Nat Methods"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-024-01914-4","article-title":"Spatial transcriptomic analysis of primary and metastatic pancreatic cancers highlights tumor microenvironmental heterogeneity","volume":"56","author":"Khaliq","year":"2024","journal-title":"Nat Genet"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41587-022-01448-2","article-title":"The expanding vistas of spatial transcriptomics","volume":"41","author":"Tian","year":"2023","journal-title":"Nat Biotechnol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.talanta.2023.125052","article-title":"DBAN: An improved dual branch attention network combined with serum Raman spectroscopy for diagnosis of diabetic kidney disease","volume":"266","author":"Chen","year":"2024","journal-title":"Talanta"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202514661","article-title":"Spatial transcriptomics and snRNA-seq expose CAF niches orchestrating dual stromal-immune barriers in hepatocellular carcinoma","volume":"12","author":"Li","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.aeb3800","article-title":"Disrupting USP14-mediated PARP1 dynamics reinstates MIC-A\/B-driven antigen-independent CD8+ T cell killing in glioma","volume":"12","author":"Wang","year":"2026","journal-title":"Sci Adv"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1001216","article-title":"Reporting recommendations for tumor marker prognostic studies (REMARK): explanation and elaboration","volume":"9","author":"Altman","year":"2012","journal-title":"PloS Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2022.105697","article-title":"Evaluating the performance of dropout imputation and clustering methods for single-cell RNA sequencing data","volume":"146","author":"Xu","year":"2022","journal-title":"Comput Biol Med"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2023.106873","article-title":"MLSpatial: A machine-learning method to reconstruct the spatial distribution of cells from scRNA-seq by extracting spatial features","volume":"159","author":"Zhu","year":"2023","journal-title":"Comput Biol Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.1000412","article-title":"Improving bioscience research reporting: The ARRIVE guidelines for reporting animal research","volume":"8","author":"Kilkenny","year":"2010","journal-title":"PloS Biol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21165939","article-title":"CA9 silencing promotes mitochondrial biogenesis, increases putrescine toxicity and decreases cell motility to suppress ccRCC progression","volume":"21","author":"Xu","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-021-01971-7","article-title":"Positive feedback regulation of lncRNA PVT1 and HIF2\u03b1 contributes to clear cell renal cell carcinoma tumorigenesis and metastasis","volume":"40","author":"Zhang","year":"2021","journal-title":"Oncogene"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1021\/acsomega.5c01337","article-title":"Using multiomics and machine learning: Insights into improving the outcomes of clear cell renal cell carcinoma via the SRD5A3-AS1\/hsa-let-7e-5p\/RRM2 axis","volume":"10","author":"Sun","year":"2025","journal-title":"ACS Omega"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.3892\/ijo.2019.4736","article-title":"Potential tumor-suppressive role of microRNA-99a-3p in sunitinib-resistant renal cell carcinoma cells through the regulation of RRM2","volume":"54","author":"Osako","year":"2019","journal-title":"Int J Oncol"},{"key":"B23","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1152\/physrev.00044.2005","article-title":"The NOX family of ROS-generating NADPH oxidases: physiology and pathophysiology","volume":"87","author":"Bedard","year":"2007","journal-title":"Physiol Rev"},{"key":"B24","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1016\/j.mam.2008.05.005","article-title":"Regulation of glutathione synthesis","volume":"30","author":"Lu","year":"2009","journal-title":"Mol Aspects Med"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202411081","article-title":"Branched-chain \u03b1 keto-acid dehydrogenase kinase-mediated AKT phosphorylation promotes RCC tumorigenesis and drug resistance","volume":"12","author":"Tian","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-20-3979","article-title":"mTOR activation initiates renal cell carcinoma development by coordinating ERK and p38MAPK","volume":"81","author":"Wu","year":"2021","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"Nature"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-018-0178-0","article-title":"BAP1 links metabolic regulation of ferroptosis to tumour suppression","volume":"20","author":"Zhang","year":"2018","journal-title":"Nat Cell Biol"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2024.108198","article-title":"Identification of cuproptosis-related lncRNAs with the significance in prognosis and immunotherapy of oral squamous cell carcinoma","volume":"171","author":"Gong","year":"2024","journal-title":"Comput Biol Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1177\/0022034516678203","article-title":"The role of Pannexin 3 in bone biology","volume":"96","author":"Ishikawa","year":"2017","journal-title":"J Dent Res"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1038\/nature09413","article-title":"Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis","volume":"467","author":"Chekeni","year":"2010","journal-title":"Nature"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1042\/BJ20140447","article-title":"Pannexin channels and their links to human disease","volume":"461","author":"Penuela","year":"2014","journal-title":"Biochem J"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2024.114269","article-title":"PANX2 promotes Malignant transformation of colorectal cancer and 5-Fu resistance through PI3K-AKT signaling pathway","volume":"442","author":"Zhang","year":"2024","journal-title":"Exp Cell Res"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.670138","article-title":"Integrated analysis of ceRNA network reveals prognostic and metastasis associated biomarkers in breast cancer","volume":"11","author":"Qian","year":"2021","journal-title":"Front Oncol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.2147\/OTT.S249752","article-title":"Identification of Pannexin 2 as a novel marker correlating with ferroptosis and Malignant phenotypes of prostate cancer cells","volume":"13","author":"Liao","year":"2020","journal-title":"Onco Targets Ther"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1883667\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T05:31:49Z","timestamp":1785735109000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2026.1883667\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,3]]},"references-count":35,"alternative-id":["10.3389\/fimmu.2026.1883667"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2026.1883667","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,3]]},"article-number":"1883667"}}